You just read:

Idiopathic Pulmonary Fibrosis Report 2016: FDA simultaneously approved both Esbriet and Ofev in October 2014, making them the first treatments specifically approved for IPF in the US - Research and Markets

News provided by

Research and Markets

Aug 12, 2016, 08:10 ET